home / stock / mrsn / mrsn news

MRSN News and Press, Mersana Therapeutics Inc.

Stock Information
Company Name: Mersana Therapeutics Inc.
Stock Symbol: MRSN
Market: NASDAQ
Website: mersana.com
Menu
MRSN MRSN Quote MRSN Short MRSN News MRSN Articles MRSN Message Board
Get MRSN Alerts

News, Short Squeeze, Breakout and More Instantly...
MRSN - SBRA, GH and CRBU are among after hour movers

2024-05-20 16:47:47 ET Gainers: Maravai LifeSciences  ( MRVI ) +5% . Caribou Biosciences ( CRBU ) +4% . Greenidge Generation Holdings  ( GREE ) +4% . Cipher Mining  ( CIFR ) +4% . SIGA Technologies  ( SIGA ) +4%...
MRSN - Mersana Therapeutics: On Hold While Waiting For Any Positive News

2024-05-15 09:56:00 ET Summary Mersana Therapeutics, Inc. is a cancer-focused biotech with two pipeline projects in phase 1 clinical study. Their lead compounds, XMT-1660 and XMT-2056, target novel immune checkpoints and HER2, respectively. The company has enough cash to suppo...

MRSN - Mersana Therapeutics, Inc. (MRSN) Q1 2024 Earnings Call Transcript

2024-05-09 14:09:08 ET Mersana Therapeutics, Inc. (MRSN) Q1 2024 Earnings Conference Call May 09, 2024 08:00 AM ET Company Participants Jason Fredette - Senior Vice President, Investor Relations & Corporate Communications Martin Huber - President & Chief Exec...

MRSN - Mersana Therapeutics GAAP EPS of -$0.16 beats by $0.02, revenue of $9.25M beats by $0.75M

2024-05-09 07:21:47 ET More on Mersana Therapeutics Mersana Therapeutics, Inc. (MRSN) Q4 2023 Earnings Call Transcript Mersana Therapeutics Q1 2024 Earnings Preview Mersana Therapeutics GAAP EPS of -$0.16 in-line, revenue of $10.7M misses by $4.07M Seeking Al...
MRSN - Mersana Therapeutics Provides Business Update and Announces First Quarter 2024 Financial Results

Maximum tolerated dose not yet established in Phase 1 clinical trial of XMT-1660; enrollment in dose escalation and backfill cohorts continuing in parallel; expect to announce initial clinical data and initiate expansion in the second half of 2024 Patient recruitment ongoing in Phase 1 cl...

MRSN - Notable earnings before Thursday's open

2024-05-08 12:34:51 ET Major earnings expected before the bell on Thursday include: Medical Properties Trust ( MPW ) Plug Power ( PLUG ) Roblox ( RBLX ) Viatris ( VTRS ) Warner Bros. Discovery ( WBD ) Read the full article on Seeking Alpha ...

MRSN - Mersana Therapeutics Q1 2024 Earnings Preview

2024-05-08 11:45:14 ET More on Mersana Therapeutics Mersana Therapeutics, Inc. (MRSN) Q4 2023 Earnings Call Transcript Mersana Therapeutics GAAP EPS of -$0.16 in-line, revenue of $10.7M misses by $4.07M Mersana Therapeutics Q4 2023 Earnings Preview Seeking Al...
MRSN - Mersana Therapeutics to Host First Quarter 2024 Conference Call on May 9, 2024

CAMBRIDGE, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that ...

MRSN - Trend Tracker for (MRSN)

2024-03-18 08:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

MRSN - AVLX, SGH and ETNB are among pre market losers

2024-03-15 16:48:33 ET Gainers: 89bio  ( ETNB ) +5% . Black Diamond Therapeutics ( BDTX ) +5% . Anavex Life Sciences  ( AVXL ) +3% . iHeartMedia ( IHRT ) +2% . SMART Global Holdings ( SGH ) +2% . Losers: CERo Th...
Next 10